Clinical Trial Update: Propofol Cardioprotection for Type II Diabetics [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials completed evaluating propofol for cardioprotection in patients with type 2 diabetes experiencing myocardial injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Injury

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

Sponsor: University of British Columbia | Conditions: Myocardial Injury | Phase 2, Phase 3 | Status: COMPLETED